Our staff accumulates more than 25 years of experience in the pharmaceutical and biotechnology industry. Through our laboratory of the S2B Technology Park of Tres Cantos, we offer our clients different services for the automation of their laboratory processes and the treatment of the generated data; For this we use the most advanced and modern robotic technology connected to our LIMS systems.
- A company based in Madrid
- A 100% private company
- Located inside the Technology Park of Madrid.
- Specialized management team with more than 25 years of experience in the sector
- With a wide range of clients, from the Pharmaceutical Industry to Biotechnology, including Petrochemicals, Renewable Energies and Academic Centers
TEAM
- Drug Discovery
- Cytotoxicity
- Drug Metabolism
- Microbiology
- Compound Extraction
- Process Quality Control, etc
GENOVEVA MATEOS BUATTI
Director of the Laboratory and Founder
Degree in Biology and Master in Biophysics.
Automation Specialist at EYOWN TECHNOLOGIES S.L.
Professional with 11 years of experience in the field of drug discovery, manufacturing, performing various types of biochemical and cellular assays, and automation of laboratory processes in centres such as the Spanish National Cancer Research Centre (CNIO), the pharmaceutical industry (Merck, Sharp & DOHME) and the company MEJORAN LAB AUTOMATION SL.
jUAN BAUTISTA CRESPO GARCIA
Scientific Director and Founder
Degree in Biology, specialising in Microbiology and Biochemistry. Director and Founder of EYOWN TECHNOLOGIES S.L.
Professional with 26 years of experience in the pharmaceutical industry, drug discovery, manufacturing, data management (LIMS) and laboratory automation.
Director and Founder of MEJORAN LAB AUTOMATION SL, Senior Associate at the Centre for Basic Research (CIBE), Merck, Sharp & DOHME. Author of 10 publications in international journals.
ENRIQUE ORTUÑO
Head of Business Development
Degree in Biology, specialising in Genetics
Professional with 21 years of experience in the commercialisation of instrumentation and reagents in the area of biotechnology in companies such as Tecan, Bonsai Technologies or Ecogen. Of these, 14 specialised in laboratory automation equipment.
5 years of experience in research laboratory (INIA) with 7 international publications.
MERVE KESER
R&D PH CELLOW
“Graduate in Biochemistry and Master in Biopharmaceutical Sciences with specialisation in Systems Biomedicine and Pharmacology.
Professional experience focuses on biotechnology, mainly on protein engineering and characterisation in green chemistry and biocatalysis, as well as analytical chemistry techniques in MS and chromatography”.
Student ESR9 in GA No 813006 – ImplantSens H2020-MSCA-ITN-2018.
JOSE CARLOS LUQUE VILLALTA
Laboratory technician and administration
Bachelor’s degree in Biology and Master’s degree in Health Biotechnology.
Specialisation in molecular biology and proteomics, Andalusian Centre for Developmental Biology (CABD).
Professional with 8 years of experience in the biotechnology sector, in the field of production and purification of drugs for animal health, quality control under GMP regulations and various types of biochemical, molecular and cellular assays.
VIRGINIA OSENDE ROBERT
Responsible for web development and web design.
Master in Digital Design, Master in Web Design, Master in Graphic Design. Online manager course for the development of websites and e-commerce. Course on innovation in the e-commerce sales process and community management (CEC). Course to promote commerce through the design of your website (AEFI). Master’s degree in project management. Community manager and search engine optimisation course (CEC).
More than 12 years of experience in web maintenance, digital design, graphic design, web direction and management, community manager and web development.
SCIENTIFIC ADVISORY COMMITTEE
jOSE MARÍA SANCHEZ-PUELLES
Senior Researcher (CIP-CSIC)
59 years old, PhD in Biology, Research Scientist at the CSIC.
of CSIC, he leads the Molecular Pharmacology group in the Department of Molecular Biomedicine of the Centre for Biological Research (CIP-CSIC).
36 years of experience in research, 22 years in academic institutions. 14 years in R&D in the pharmaceutical industry, 12 years as R&D Director in the international area of Drug Discovery at Merck, Sharp & Dohme, SmithKline Beecham and PharmaMar. Member of the International R&D Scientific Committee of these pharmaceutical companies.
Author of 46 publications in international journals and responsible for 40 international patents for new compounds and processes. Invited lecturer at national and international public and private research institutions.
Evaluator for the European Commission, Ministry of Education and Science and the Ministry of Industry, member of the Steering Committee of European Consortia as representative of MINECO (ERA-NETs and JPIs). Consultant to pharmaceutical and biotechnology companies (e.g., Genentech, GlaxoSmithKline, MGMis, Mejor@n, eYOWN, DOMCA).
Founder of two biomedical biotechnology companies, BioSafety and eYOWN.
mIGUEL ALCALDE CALEOTE
Senior Researcher (ICP-CSIC)
He studied biology at the Complutense University of Madrid, Spain (1988-1993) and in 1994 obtained a master’s degree in plant physiology.
In 1999, he completed his PhD in biochemistry and molecular biology at the Institute of Catalysis (ICP-CSIC, Madrid).
From 2001 to 2003, Dr. Alcalde took a postdoctoral position at CALTECH under the direction of Prof. Frances H. Arnold.
After his return to ICP-Madrid, he was appointed CSIC staff scientist and promoted to CSIC researcher in 2014.
He has participated in more than 10 consecutive European projects and several research contracts with industries.
He is co-author of several patents and more than 100 SCI articles.
Founder of EvoEnzyme, derived from ICP-CSIC (www.evoenzyme.com).
RIANSARES MUÑOZ OLIVAS
Professor of the Analytical Dept., Faculty of Chemistry, UCM.
She studied Chemistry at the Universidad Autónoma de Madrid (1986-1991) and obtained her PhD in Analytical Chemistry and Environment at the Université de Bordeaux I in 1996.
Subsequently, she joined the Analytical Chemistry Department of the UCM with a Reincorporation contract from the Ministry of Education and Science, and between 2001 and 2005 she was a beneficiary of a grant from the Ramón y Cajal programme for suitable researchers.
In terms of teaching, she was Associate Professor at the University of Huelva, and since 2005 she has been employed at the UCM, first as Associate Professor and since 2008 as Full Professor, combining these tasks with the position of Vice-Dean of Students at the Faculty of Chemistry from 2010 to 2018.
She has carried out several pre- and post-doctoral stays in international centres (France, Italy, UK, USA); she is co-author of more than 50 scientific articles, four multi-authored books and two patents.
She has participated in more than 20 nationally and internationally funded research projects.
She has co-directed 6 doctoral theses.
She is currently working on several research lines, all of them related to metal contaminants and nanoparticles in different solid samples of environmental and biological interest.
Juan Manuel Domínguez Correa
Consultant, Drug Discovery Expert
Juan Manuel Domínguez obtained his PhD degree at Universidad Complutense de Madrid, where he was honored with both Graduation and Doctorate Extraordinary Awards in 1987 and 1992 respectively.
During his stay in Academia he became skilled in enzymology and protein biochemistry and afterwards he moved to the pharmaceutical industry, where he has worked for nearly 30 years on research in the early stages of the drug discovery process. He joined Glaxo in 1992 as Investigator of the Biochemistry Department, focused on the discovery of novel anti-infective agents as well as on the determination of their mechanism of action. In 2001 he was appointed Manager of the Assay Development Department in GlaxoSmithKline, responsible for the biochemical characterization of therapeutic targets, the design of biological assays for ultra-high throughput screening and the execution of mode of action studies on selected hits. During this period he led international projects involving scientists who were expert in several disciplines and has worked in laboratories outside Spain. In 2008 he started to work for companies of the PharmaMar group, first in Noscira where he directed the Drug Discovery Department and since 2013 at PharmaMar where he ran the Screening Department. He has authored more than 40 publications and book chapters as well as several patents and oral presentations. Member of the Editorial Board of the Journal of Biomolecular Screening between 2012 and 2017, he is a frequent reviewer of works for several renowned publications in the drug discovery field such as SLAS Discovery, Biochemical Pharmacology or Theranostics. He also collaborates as a lecturer in various postgraduate masters at Universidad Complutense de Madrid and Universidad Autónoma de Madrid.
PARTNERS
Customers
